Showing 1 - 20 results of 55 for search '"бактериальная транслокация"', query time: 0.72s Refine Results
  1. 1
    Academic Journal

    Source: Russian Journal of Transplantology and Artificial Organs; Том 26, № 4 (2024); 178-183 ; Вестник трансплантологии и искусственных органов; Том 26, № 4 (2024); 178-183 ; 1995-1191

    Relation: https://journal.transpl.ru/vtio/article/downloadSuppFile/1794/1624; https://journal.transpl.ru/vtio/article/downloadSuppFile/1794/1625; https://journal.transpl.ru/vtio/article/downloadSuppFile/1794/1626; Резник ОН, Резник АО. Социальные основы диалога о посмертном донорстве органов. Вестник трансплантологии и искусственных органов. 2023; 25 (4): 174–180. https://doi.org/10.15825/19951191-2023-4-174-180.; Салимов УР, Щерба АЕ, Руммо ОО. Бактериальные осложнения после трансплантации печени. Перспективы дальнейших исследований. Трансплантология. 2023; 15 (2): 238–250.; Шабунин АВ, Лоран ОБ, Пушкарь ДЮ, Велиев ЕИ, Минина МГ, Дроздов ПА и др. Комплексный подход к профилактике развития отсроченной функции почечного трансплантата. Вестник трансплантологии и искусственных органов. 2023; 25 (2): 8–14.; Кузьмин ДО, Мануковский ВА, Багненко СФ, Резник ОН, Ананьев АН, Воробьева ОА и др. Применение поликлональных антител у доноров со смертью мозга при пересадке почек. Вестник трансплантологии и искусственных органов. 2022; 24 (4): 124–134.; Bera KD, Shah A, English MR, Harvey D, Ploeg RJ. Optimisation of the organ donor and effects on transplanted organs: a narrative review on current practice and future directions. Anaesthesia. 2020 Sep; 75 (9): 1191–1204. https://doi.org/10.1111/anae.15037.; Тюрин ЕО, Якубцевич РЭ. Современный взгляд на кондиционирование доноров со смертью головного мозга. Журнал Гродненского государственного медицинского университета. 2022; 20 (5): 485–493.; Zirpe K, Gurav S. Brain Death and Management of Potential Organ Donor: An Indian Perspective. Indian J Crit Care Med. 2019 Jun; 23 (Suppl 2): S151–S156. doi:10.5005/jp-journals-10071-23194. PMID: 31485125; PMCID: PMC6707496.; Kane TD, Johnson SR, Alexander JW, Craycraft TK. Bacterial translocation in organ donors: clinical observations and potential risk factors. Clin Transplant. 1997; 11 (4): 271–274.; Uçar Bİ, Uçar GI. Intestinal Barrier Dysfunction, Bacterial Translocation and Inflammation: Deathly Triad in Sepsis. Infections and Sepsis Development. IntechOpen. 2021 Oct 27: 303–328. doi:10.5772/intechopen.99554.; Moharem HA, Fetouh FA, Darwish HM, Ghaith D, Elayashy M, Hussein A et al. Effects of bacterial translocation on hemodynamic and coagulation parameters during living-donor liver transplant. BMC Anesthesiol. 2018 Apr 25; 18 (1): 46. doi:10.1186/s12871-018-0507-7. PMID: 29699477; PMCID: PMC5921288.; Rodríguez-Laiz GP, Zapater P, Melgar P, Alcázar C, Franco M, Giménez P et al. Liver Transplantation Group. Bacterial DNA translocation contributes to systemic inflammation and to minor changes in the clinical outcome of liver transplantation. Sci Rep. 2019 Jan 29; 9 (1): 835. doi:10.1038/s41598-018-36904-0. PMID: 30696924; PMCID: PMC6351615.; Carron C, Pais de Barros JP, Gaiffe E, Deckert V, Adda-Rezig H, Roubiou C et al. End-Stage Renal DiseaseAssociated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation. Front Immunol. 2019 Aug 16; 10: 1630. doi:10.3389/fimmu.2019.01630.; https://journal.transpl.ru/vtio/article/view/1794

  2. 2
    Academic Journal

    Source: Meditsinskiy sovet = Medical Council; № 18 (2023); 160-165 ; Медицинский Совет; № 18 (2023); 160-165 ; 2658-5790 ; 2079-701X

    File Description: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/7859/6980; Zheng D, Zhou H, Wang H, Zhu Y, Wu Y, Li Q, Li T, Liu L. Mesenchymal stem cell-derived microvesicles improve intestinal barrier function by restoring mitochondrial dynamic balance in sepsis rats. Stem Cell Res Ther. 2021;12(1):299. https://doi.org/10.1186/s13287-021-02363-0.; Assimakopoulos SF, Triantos C, Thomopoulos K, Fligou F, Maroulis I, Marangos M, Gogos CA. Gut-origin sepsis in the critically ill patient: pathophysiology and treatment. Infection. 2018;46(6):751–760. https://doi.org/10.1007/s15010-018-1178-5.; Vaishnavi C. Translocation of gut flora and its role in sepsis. Indian J Med Microbiol. 2013;31(4):334–342. https://doi.org/10.4103/0255-0857.118870.; Подопригора ГИ, Кафарская ЛИ, Байнов НА, Шкопоров АН. Бактериальная транслокация из кишечника: микробиологические, иммунологические и патофизиологические аспекты. Вестник Российской академии меди­ цинских наук. 2015;(6):640–650. https://doi.org/10.15690/vramn564.; Nelson DB. Infectious disease complications of GI endoscopy: part II, exogenous infections. Gastrointest Endosc. 2003;57(6):695–711. https://doi.org/10.1067/mge.2003.202.; Khashab MA, Chithadi KV, Acosta RD, Bruining DH, Chandrasekhara V, Eloubeidi MA et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2015;81(1):81–89. https://doi.org/10.1016/j.gie.2014.08.008.; Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007;147(12):829–835. https://doi.org/10.7326/0003-4819-147-12-200712180-00002.; Akuzawa N, Kurabayashi M. Native valve endocarditis due to Escherichia coli infection: a case report and review of the literature. BMC Cardiovasc Disord. 2018;18(1):195. https://doi.org/10.1186/s12872-018-0929-7.; Watanakunakorn C, Burkert T. Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes. Medicine (Baltimore). 1993;72(2):90–102. https://doi.org/10.1097/00005792-199303000-00003.; Kim CJ, Yi JE, Kim Y, Choi HJ. Emphysematous endocarditis caused by AmpC beta-lactamase-producing Escherichia coli: A case report. Medicine (Baltimore). 2018;97(6):e9620. https://doi.org/10.1097/MD.0000000000009620.; Tsutsumi T, Hiraoka E, Kanazawa K, Akita H, Eron LJ. Diagnosis of E. coli tricuspid valve endocarditis: a case report. Hawaii Med J. 2010;69(12):286. Available at: https://pubmed.ncbi.nlm.nih.gov/21225584.; Spaleniak S, Romejko-Ciepielewska K, Lubas A, Ryczek R, Niemczyk S. Infective endocarditis in the course of urosepsis E. coli ESBL(+) in a patient with Goodpasture’s syndrome. Kardiol Pol. 2015;73(8):670. https://doi.org/10.5603/KP.2015.0154.; Nikolich-Žugich J. Author Correction: The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19(10):1146. https://doi.org/10.1038/s41590-018-0205-0.; Tamura J, Kubota K, Murakami H, Sawamura M, Matsushima T, Tamura T, Saitoh T, Kurabayshi H, Naruse T. Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin Exp Immunol. 1999;116(1):28–32. https://doi.org/10.1046/j.1365-2249.1999.00870.x.; Yumoto T, Kono Y, Kawano S, Kamoi C, Iida A, Nose M et al. Citrobacter braakii bacteremia-induced septic shock after colonoscopy preparation with polyethylene glycol in a critically ill patient: a case report. Ann Clin Microbiol Antimicrob. 2017;16(1):22. https://doi.org/10.1186/s12941-017-0201-5.; Darrow CJ, Devito JF. An occurrence of sepsis during inpatient fecal disimpaction. Pediatrics. 2014;133(1):e235–239. https://doi.org/10.1542/peds.2012-2963.; Cullender TC, Chassaing B, Janzon A, Kumar K, Muller CE, Werner JJ et al. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe. 2013;14(5):571–581. https://doi.org/10.1016/j.chom.2013.10.009.; Barbara G, Scaioli E, Barbaro MR, Biagi E, Laghi L, Cremon C et al. Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease. Gut. 2017;66(7):1252–1261. https://doi.org/10.1136/gutjnl-2016-312377.; Nagata N, Tohya M, Fukuda S, Suda W, Nishijims A, Takeuchi F et al. Effects of bowel preparation on the human gut microbiome and metabolome. Sci Rep. 2019;9(1):4042. https://doi.org/10.1038/s41598-019-40182-9.; Drago L, Toscano M, De Grandi R, Casini V, Pace F. Persisting changes of intestinal microbiota after bowel lavage and colonoscopy. Eur J Gastroenterol Hepatol. 2016;28(5):532–537. https://doi.org/10.1097/MEG.0000000000000581.; Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538–541. https://doi.org/10.1038/nature10554.

  3. 3
    Academic Journal
  4. 4
  5. 5
  6. 6
  7. 7
    Academic Journal

    Authors: Burak, A. Ye.

    Source: Hospital Surgery. Journal named by L.Ya. Kovalchuk; No. 4 (2017); 17-21 ; Госпитальная хирургия. Журнал имени Л.А. Ковальчука; № 4 (2017); 17-21 ; Шпитальна хірургія. Журнал імені Л. Я. Ковальчука; № 4 (2017); 17-21 ; 2414-4533 ; 1681-2778 ; 10.11603/2414-4533.2017.4

    File Description: application/pdf

  8. 8
    Academic Journal
  9. 9
  10. 10
    Academic Journal

    Source: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 14, № 2 (2017); 5-13 ; Вестник анестезиологии и реаниматологии; Том 14, № 2 (2017); 5-13 ; 2541-8653 ; 2078-5658

    File Description: application/pdf

    Relation: https://www.vair-journal.com/jour/article/view/143/181; Полушин Ю. С., Афанасьев А. А., Малышев М. Ю., Пивоварова Л. П. Клинико-диагностическое значение уровня прокальцитонина у пострадавших с тяжелой сочетанной травмой // Вестн. анестезиол. и реаниматол. – 2015. – Т. 12. – № 1. – С. 46–54.; Dahaba A. A., Metzler H. Procalcitonin's role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator? // Minerva Anestesiologica. – 2008. – Vol. 75, № 7-8. – P. 447–452.; Dandona P. et al. Procalcitonin increase after endotoxin injection in normal subjects // J. Clin. Endocrinology & Metabolism. – 1994. – Vol. 79, № 6. – P. 1605–1608.; Meisner M. Procalcitonin – a new, innovative infection parameter. – Berlin: Brahms Diagnostica, 1996. – P. 3–41.; Whang K. T., Vath S. D., Becker K. L. et al. Procalcitonin and proinflammatory cytokine interactions in sepsis // Shock. – 2000. – Vol. 14, № 1. – P. 73–78.; Wojtaszek M., Staśkiewicz G., Torres K., Jakubowski K., Rácz O., Cipora E. Changes of procalcitonin level in multiple trauma patients //Anaesthesiology Intensive Therapy. – 2014. – Vol. 46, № 2. – Р. 78–82.; Zelzer S. et al. Comparative study of the immunological marker IL-6 and the non-immunological marker PCT in surgery patients with infections and multiple trauma // Open Pathology J. – 2009. – Vol. 3. – P. 124–130.

  11. 11
    Academic Journal

    Source: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 12, № 1 (2015); 46-53 ; Вестник анестезиологии и реаниматологии; Том 12, № 1 (2015); 46-53 ; 2541-8653 ; 2078-5658

    File Description: application/pdf

    Relation: https://www.vair-journal.com/jour/article/view/9/82; Политравма: травматическая болезнь, дисфункция иммунной системы, современная стратегия лечения / под ред. Е. К. Гуманенко и В. К. Козлова. - М.: ГЭОЕФЗ-Медиа, 2008. - 608 с.; Полушин Ю. С., Афанасьев А. А., Пивоварова Л. П. и др. Секреторный иммуноглобулин А (sIgA) как маркёр бактериальной транслокации при тяжёлой сочетанной травме // Вестник анестезиол. и реаниматол. - 2014. - № 6. - С. 51-58.; Bistrian B. R. Acute phase proteins and the systemic inflammatory response // Crit. Care Med. - 1999. - Vol. 27, № 3. - P. 452-453.; Dandona P., Nix D., Wilson M. F. Procalcitonin increase after endotoxin injection in normal subjects // J. Clin. Endocrinol. Metab. - 1994. - Vol. 79, № 6. - P. 1605-1608.; Giannoudis P., Smith R. M., Evans R. T. Serum CRP and IL-6 levels after trauma: not predictive of septic complications // Acta Orthop. Scand. - 1998. - № 69. - Р. 184-188.; Karzai W., Oberhoffer M., Meier-Hellmann A. et al. Procalcitonin - a new indicator of systemic response to severe infection // Infection. - 1997. - Vol. 25. № 6. - P. 329-334.; Le J., Vilcek J. Interleukin-6: a multifunctional cytokine regulating immune reactions and the acute phase protein response // Lab. Invest. - 1989. - № 61. - Р. 588-602.; Meisner M., Adina H., Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications and outcome during the intensive care unit course of multiple-trauma patients // Crit. Care. - 2006. - Vol. 10, № 1. - Р. 1.; Oberhoffer M., Bigel D., Meier-Hellmann A. Procalcitonin is immunological markers in infection inflammation // Brit. J. Anaesth. - 1996. - Vol. 76. - Р. 352.; Nylen E. S., Snider R. H., Thompson K. A. Pneumonitis-associated hyperprocalcitoninemia // Amer. J. Med. Sci. - 1996. - Vol. 312, № 1. - P. 12-18.; Pierre E., Sylvain L., Serge A. Serum PCT elevation in critically ill patients at the onset of bacteremia caused by either gram-negative or gram-positive bacteria // BMC. Infect. Dis. -2008. - Vol. 8. - P. 38-39.; Quenot J.-P., Luyt C.-E., Roche N. et al. Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy // An. Intens. Care. - 2013. - № 3. - P. 21.; Russwurms S., Wiederhold W., Oberhoffer M. et al. Procalcitonin as monocyte marker for early diagnosis in septic abortus [in German] // Z. Geburtsh Neonatol. - 1999. - № 14. - P. 29-33.; Schuetz Р., Matthias B., Christ-Crain M. et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis // Clin. Infect. Dis. - 2012. - № 55. - P. 651-662.; Schuetzn P., Maurer P., Punjabi V. et al. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients // Crit. Care. - 2013. - № 17. - P. 115.; Soni N., Samson D., Galaydick J. L. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis // J. Hosp. Med. - 2013. - № 9. - Р. 530-540.; Wicher J., Bienvenu J., Monneret G. Procalcitonin as an acute phase marker // Ann. Clin. Biochem. - 2001. - Vol. 38. - P. 483-493.; Uzzan B., Cohen R., Nicolas P. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis // Crit. Care Med. - 2006. - Vol. 34, № 7.; Zelzer S., Aigner R. M., Khoschsorur G. et al. Comparative study of the immunological marker IL-6 and the non-immunological marker PCT in surgery patients with infections and multiple trauma // Open Pathol. J. - 2009. - № 3. - P. 124-130.

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
    Academic Journal

    File Description: application/pdf

    Relation: Ярмола Т. І. Стан мікрофлори кишечника у хворих на хронічний пієлонефрит / Т. І. Ярмола, Г. Л. Пустовойт, Л. А. Ткаченко // Актуальні проблеми сучасної медицини. – 2010. – Т. 10, № 2. – C. 126–128.; https://repository.pdmu.edu.ua/handle/123456789/8980

  19. 19
    Academic Journal

    File Description: application/pdf

    Relation: Роль бактеріальної транслокації у патогенезі хронічного пієлонефриту / Г. Л. Пустовойт, Ю. А. Кострікова, Т. І. Ярмола [та ін.] // Світ медицини та біології. – 2010. – № 3. – С. 28–31.; УДК 616. 61 – 002.3 – 092: 616.98; https://repository.pdmu.edu.ua/handle/123456789/3887

  20. 20